An evaluation of the program will be
conducted in a home or office setting with 80 pain management
providers (PMPs) such as physicians, NPs, and PAs. The proposed
evaluation design is a two-group (intervention and control group),
randomized trial with a crossover component. The major hypotheses
for the proposed evaluation are: 1) PMPs in the intervention group
will show greater gains in knowledge and improvements in attitude
(from pre- to post-assessment) than participants in the control
group; 2) PMPs in the intervention group will show greater gains in
clinical skills as measures than those in the control group; and 3)
PMPs in the intervention group will retain changes in knowledge,
attitudes and skills over the follow-up period of six to nine
weeks.
US Code:
42
USC 191 Name of Law: General Purpose of NIDA
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.